Sort
21,281 grants matching “influenza”
Structure, dynamics and variation in influenza hemagglutinin-driven fusion
$396,667Kelly Keisen Lee · University Of Washington · R01 · FY2018 · GM
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$396,549Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Models for synthesising molecular, clinical and epidemiological data, and transla
$396,544Neil Morris Ferguson · Imperial College Of Science, Technology And Medicine · U01 · FY2018 · GM
CAREER: Electrochemical Dynamic Midinfrared Metasurface for Ultra-Low Power Wearable Thermoregulation
$396,513Po-Chun Hsu · Duke University · · FY2022 · ENG
Cellular Immunity and Memory to SARS-CoV-2
$396,512Elizabeth B Norton · Tulane University Of Louisiana · U54 · FY2022 · CA
Forecasting Trachoma Control
$396,495Thomas M Lietman · University Of California, San Francisco · R01 · FY2018 · EY
Prevention of Inflammatory Lung Injury After Chlorine Exposure
$396,465Michael D Gunn · Duke University · U01 · FY2009 · ES
Adenoviral Vector-based Pandemic Influenza Vaccine
$396,429Suresh K Mittal · Purdue University · R01 · FY2015 · AI
PROJECT 2: INNATE IMMUNITY
$396,354Rafi Ahmed · Emory University · U19 · FY2024 · AI
Liposomal Encapsulation Vaccine Design for Pneumococcal Disease in Aged Subjects
$396,319Blaine A. Pfeifer · State University Of New York At Buffalo · R01 · FY2025 · AG
Molecular regulation of immunity to viral infections
$396,250Jin Wang · Baylor College Of Medicine · R01 · FY2016 · AI
Airway epithelial defense and interferon
$396,238Michael Jay Holtzman · Washington University · U19 · FY2014 · AI
The role of Bik in the replication and severity of influenza A virus
$396,208Yohannes Afework Mebratu · Ohio State University · R01 · FY2024 · AI
The role of Bik in the replication and severity of influenza A virus
$396,208Yohannes Afework Mebratu · Ohio State University · R01 · FY2025 · AI
Specificity and Function of CD25+ Regulatory T Cells
$396,157Andrew J Caton · Wistar Institute · R01 · FY2013 · AI
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells
$396,117Paul R Knight · State University Of New York At Buffalo · R21 · FY2010 · AI
Microcarrier / CEF / Media SYSTEM to make Viral Vaccines
$396,090Solohill Engineering, Inc. · R44 · FY2002 · AI
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
$396,072Peter C Doherty · St. Jude Children'S Research Hospital · R01 · FY2010 · AI
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
$396,000David Bram Lewis · Stanford University · R01 · FY2012 · AI
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
$396,000David Bram Lewis · Stanford University · R01 · FY2011 · AI
Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps
$395,980Maureen L. Mulvihill · Actuated Medical, Inc. · R44 · FY2020 · DK
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$395,967Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Microcarrier / CEF / Media SYSTEM to make Viral Vaccines
$395,902Solohill Engineering, Inc. · R44 · FY2001 · AI
Mechanisms of Vascular Leakage in Viral Hemorrhagic Fevers
$395,825Daniel H. Libraty · Univ Of Massachusetts Med Sch Worcester · U19 · FY2009 · AI
Influence of aging on T follicular helper (Tfh) cells
$395,724Laura Haynes · Trudeau Institute, Inc. · P01 · FY2012 · AG